Form 10-Q INTEGRA LIFESCIENCES For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Oppenheimer Downgrades Integra LifeSciences (IART) to Perform
May 7, 2024 6:09 AM EDTOppenheimer analyst Steven Lichtman downgraded Integra LifeSciences (NASDAQ: IART) from Outperform to Perform.
The analyst comments "Following an announced delay in manufacturing restart at IART's Boston facility, we are downgrading IART shares from Outperform to Perform and removing our $51 price target. As a... More
Integra LifeSciences (IART) PT Lowered to $26 at BofA Securities
May 7, 2024 5:38 AM EDTBofA Securities analyst Craig Bijou lowered the price target on Integra LifeSciences (NASDAQ: IART) to $26.00 (from $42.00) while maintaining a Underperform rating.
The analyst comments "The new findings from the Boston facility audit are the latest in a series of setbacks... More
